Exercise during curative chemotherapy for breast cancer has proven benefits. It helps reduce fatigue, preserve muscle strength, improve fitness, and enhance overall quality of life. Staying physically active…
With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
NEW YORK (Reuters Health) – A new biomarker – tumor-associated CD68+ macrophages — predicts poor outcomes in patients with classic Hodgkin’s lymphoma, new research indicates. About 20% of…
NEW YORK (Reuters Health) – There’s no good evidence that maintenance therapy improves the outcome of small-cell lung cancer (SCLC), according to a meta-analysis published February 25th in…
NEW YORK (Reuters Health) – In young women with stage IA1 cervical cancer, a fertility-preserving conization does not reduce survival compared to hysterectomy, researchers report in the March…
David Heber, MD, Professor of Medicine, Director, UCLA Center for Human Nutrition, discusses prostate cancer prevention, and explains why low fat diets and exercise can reduce inflammation by…
NEW YORK (Reuters Health) – Contralateral prophylactic mastectomy slightly improves breast cancer-specific survival, primarily in young women with early-stage estrogen receptor (ER)-negative disease, new research shows. “The efficacy…
NEW YORK (Reuters Health) – Although high-definition chromocolonoscopy may detect some adenomas missed with standard high-definition colonoscopy, it should not be used for routine colon cancer screening in…
David Heber, MD, Professor of Medicine, Director, UCLA Center for Human Nutrition, discusses nutrition in breast cancer, and the role of diabetes and obesity in post-menopausal breast cancer,…
NEW YORK (Reuters Health) – In selected patients with suspected early-stage gallbladder carcinoma, laparoscopy is a safe approach, Korean physicians report in the February Archives of Surgery. “Although…
NEW YORK (Reuters Health) – In patients with untreated advanced non-small-cell lung cancer (NSCLC), adding cetuximab (Erbitux) to platinum-based chemotherapy can improve overall survival and response rates, a…
NEW YORK (Reuters Health) – Three weeks of hypofractionated whole-breast radiotherapy is at least as good as 5 weeks of standard radiotherapy after breast-conserving surgery for invasive cancer,…
